New glasses for nearsighted kids: will they wear them?
NCT ID NCT07340931
First seen Jun 26, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This pilot study is testing how well children aged 6 to 16 adapt to Essilor Stellest myopia-control spectacle lenses. The goal is to see if kids find them comfortable and easy to wear in real life, which is important for long-term use. Fifty children with progressive myopia will wear the lenses and answer a questionnaire about comfort and satisfaction. This study does not test whether the lenses slow myopia, only how well children tolerate them.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
Essilor Stellest 2.0 myopia-control spectacle lenses
What this could lead to
If successful, this study could show that these lenses are comfortable and easy for children to wear daily, supporting their long-term use to slow myopia progression.
What could go wrong
This is a small, early observational study with only 50 participants. It does not measure how well the lenses control myopia, only comfort and adaptation. Results may not apply to all children.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for MYOPIA are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
CHU Nantes - Ophthalmology Department
RECRUITINGNantes, Nantes, 44000, France
Contact Phone: •••-•••-•••• Email: •••••@•••••